Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Rheumatology International
Literature
1.
Gabrielli A, Avvedimento EV, Krieg T (2009) Scleroderma. N Engl J Med 360:1989–2003CrossRef
2.
Chifflot H, Fautzi B, Sordet C, Chatelus E, Sibilia J (2008) Incidence and prevalence of systemic sclerosis: a systematic literature review. Semin Arthritis Rheum 37:223–235CrossRef
3.
Garabrant D H and Dumas C (2000) Epidemiology of organic solvents and connective tissue disease. Arthritis Res 2:5–15CrossRef
4.
Bottomley WW, Sheehan-Dare RA, Hughes P, Cunliffe WJ (1993) A sclerodermatous syndrome with unusual features following prolonged occupational exposure to organic solvents. Br J Dermatol 128:203–206CrossRef
5.
Czirják L, Schlammadinger J, Szegedi G (1993) Systemic sclerosis and exposure to trichloroethylene. Dermatology 186:236CrossRef
6.
Czirják L, Pócs E, Szegedi G (1994) Localized scleroderma after exposure to organic solvents. Dermatology 189:399–401CrossRef
7.
Flindt-Hansen H, Isager H (1987) Scleroderma after occupational exposure to trichlorethylene and Trichloroethane. Acta Derm Venereol [Stockh] 67:263–264
8.
Waldner BK (1983) Do solvents cause scleroderma? Int J Dermatol 22(3):157–158CrossRef
9.
Yamakage A, Ishikawa H (1982) Generalized morphea-like scleroderma occurring in people exposed to organic solvents. Dermatologica 165:186–193CrossRef
Metadata
Title
Diffused systemic sclerosis due to occupational solvent exposure
Authors
Gh-hossein Alishiri
Amin Saburi
Noushin Bayat
Ehsan Saburi
Publication date
01-06-2013
Publisher
Springer Berlin Heidelberg
Published in
Rheumatology International / Issue 6/2013
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-011-2347-3

Other articles of this Issue 6/2013

Rheumatology International 6/2013 Go to the issue

Letter to the Editors

Isomorphic phenomenon in discoid lupus erythematosus with review of reported cases

Short Communication

Typical Jaccoud’s arthropathy in a patient with sarcoidosis

Original Article

Thalidomide reduces recurrence of ankylosing spondylitis in patients following discontinuation of etanercept

Case Report

Polyarticular lipoma arborescens—a clinical and aesthetical case

Short Communication

Sustained hypogammaglobulinemia under rituximab maintenance therapy could increase the risk for serious infections: a report of two cases

Review

The genetics of Henoch–Schönlein purpura: a systematic review and meta-analysis
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits